Shattuck Labs grants equity awards to new non-executive officer on Dec. 10, 2025. Company is listed on NASDAQ as STTK.
In a recent announcement made on December 15, 2025, Shattuck Labs, Inc., based in Austin, TX and Durham, NC, shared that they have issued inducement equity awards to a newly hired non-executive officer. These awards were granted on December 10, 2025. Shattuck Labs is recognized as a clinical-stage biotechnology company and operates under the NASDAQ ticker symbol STTK. The company specializes in developing innovative therapeutics that target tumor necrosis factor (TNF) superfamily receptors. Their focus lies in providing treatment solutions for patients grappling with inflammatory and immune-mediated diseases.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments